FTSE 100 news / Companies and sectors / Haleon / 6 October 2026
Haleon (HLN): news on Tuesday 6 October 2026
−5.7 negative
Coverage was mainly about JPMorgan cutting its price target on Haleon from 315p to 295p and placing it on negative watch ahead of Q3 results. Commentary on softer European demand and dividend questions added to the cautious tone, while a small share price gain and an executive appointment were minor offsets.
What drove it
- JPMorgan target cut
- Q3 results caution
- European demand and dividend questions
The 7 stories
- −7.2 JPMorgan cuts target for Haleon stock from GBp 315 to GBp 295
Target lowered from 315p to 295p by JPMorgan. - −7.0 Haleon stock faces a 295 GBp JPMorgan target cut
JPMorgan cut price target to 295p, negative analyst view. - −6.7 JP Morgan places Unilever on positive watch and Haleon on negative ahead of Q3 results.
JPMorgan places Haleon on negative watch before Q3 results. - −6.3 Unilever on JP Morgan positive watch as Haleon faces caution
JPMorgan cautious on Haleon ahead of Q3 results. - −5.2 Are Softer European Demand And Dividend Questions Putting Haleon (LSE:HLN) Under The Microscope Ahead Of Its Update While FTSE 100 Trades Higher?
Softer European demand and dividend questions before update. - +1.7 Haleon Appoints Vandana Chamarla As Head Of Oral Health, South Asia
Routine senior appointment in oral health, South Asia. - +1.3 Haleon stock after-hours at EUR 3.94: plus 0.77 percent after the Xetra close
Small after-hours share price gain, largely factual.}
Haleon: every day · Pharma and healthcare on 6 October 2026 · FTSE 100 overview for the day